Contract 75A50125C00011
University Of California, Los Angeles · Department Of Health And Human Services · September 29, 2025
University Of California, Los Angeles was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 29, 2025 for $9.19 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Los Angeles, CA. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $21.60 million.
Contract details
- PIID
- 75A50125C00011
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Los Angeles, CA
- First action
- September 29, 2025
Description
FUNDING TO THE UNIVERSITY OF CALIFORNIA LOS ANGELES TO SUPPORT A NOVEL PATHOGEN AGNOSTIC DIAGNOSTIC PLATFORM NAMED THE SWABSEQ METAGENOMIC DIAGNOSTIC PLATFORM.
Modification timeline
-
September 29, 2025Base award$9.19M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50125C00011?
Contract 75A50125C00011 is a federal contract awarded to University Of California, Los Angeles by Department Of Health And Human Services on September 29, 2025 for $9.19 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75A50125C00011?
University Of California, Los Angeles won contract 75A50125C00011 from Department Of Health And Human Services.
How much is contract 75A50125C00011 worth?
Contract 75A50125C00011 has obligated $9.19 million to date, with a total potential value of $21.60 million if all options are exercised.